Harvard Pilgrim Health Care
61
1
5
54
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 61 trials
100.0%
+13.5% vs industry average
3%
2 trials in Phase 3/4
33%
18 of 54 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (61)
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
Role: collaborator
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2
Role: collaborator
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias
Role: lead
InvesT1D: Promoting Adolescent Investment in Diabetes Care
Role: lead
Clinical Decision Support for PrEP
Role: lead
Understanding Fish Consumption Habits During Pregnancy
Role: lead
INSPIRE Trial for Skin and Soft Tissue Infections
Role: lead
INSPIRE Trial for Abdominal Infections
Role: lead
ACHIEVE Pilot Statins for Vascular Protection
Role: collaborator
Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing
Role: lead
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
Role: lead
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
Role: lead
Eco-labels on Restaurant Menus
Role: lead
The INSPIRE-ASP UTI Trial
Role: lead
The INSPIRE-ASP PNA Trial
Role: lead
CLUSTER Trial for Outbreak Detection and Response
Role: lead
Front-of-Package Nutrition Labels
Role: lead
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease
Role: collaborator
Asthma in Families Facing Out-of-pocket Requirements With Deductibles
Role: lead
Surveillance Imaging Modalities for Breast Cancer Assessment
Role: collaborator